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BACKGROUND: Primary sternal malignancy is very uncommon. Secondary sternal malignancy is 
usually caused by either hematological dissemination or by direct extension due to parasternal lymph 
node involvement from breast or lung carcinoma.  
CASE DETAILS: A 72 years old smoker presented with a dull aching pain over the sternum. Computed 
tomography (CT) of the thorax revealed osteolytic erosion of manubrium sterni, along with a mass of 
lesion in the upper lobe of left lung and left sided mediastinal lymphadenopathy. CT guided fine needle 
aspiration cytology (FNAC) of the left lung mass showed squamous cell carcinoma and FNAC of the 
sternal lesion revealed metastatic squamous cell carcinoma. 
CONCLUSION: Direct erosion of sternum in case of squamous cell carcinoma of lung is a rarity. We 
have reported this case to increase the awareness of clinicians regarding the possibility of direct sternal 
involvement from lung cancer. Moreover, local removal can improve the prognosis. 






Primary tumours of the sternum are rare (0.6%– 
1%), and most of them are malignant (1).
 
Two 
thirds of sternal masses are metastatic (2). 
Metastatic tumours often come from breast, lung, 
kidney and thyroid gland while direct invasion of 
the sternum often occurs from lymphoma, 
bronchogenic carcinoma, breast cancer, pleural 
and mediastinal malignancy (2). The skeleton is a 
common site of metastasis in lung cancer. The 
lesions are usually osteolytic and often present 
with severe bone pain. However, the sternal 
involvement either due to loco-regional spread or 
by distant metastasis from lung cancer is very 
rarely reported. We report a case of loco-regional 
spread to sternal body in a patient of lung cancer 
to increase the awareness of the physicians and 
oncologists.  
CASE REPORT  
 
A 72 years old normotensive, non-diabetic male 
smoker presented with dull aching pain in the 
upper anterior chest wall adjacent to sternum, 
along with cough with scanty, white, mucoid 
expectoration for one month. His night sleep was 
disturbed due to severe chest pain which was not 
relieved by non-narcotic analgesic. He also 
complained of a gradually progressive hoarseness 
of voice for fifteen days. He had a history of 
anorexia and a significant weight loss, but there 
was no history of hemoptysis or dyspnoea. No 
past history of pulmonary tuberculosis was present 
either.  
On general survey, he had pallor, clubbing, 
and left sided supraclavicular lymphadenopathy. 
His axillary temperature, respiratory rate, pulse 
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breaths/minute, 100 beats/minute and 110/80 
mmHg respectively. On examination of respiratory 
process, the chest was acutely tendered in the left infra-
clavicular area and in sternal region, but no mass 
was palpable. Percussion note over left second and 
third intercostal spaces near parasternal area and 
over sternum was dull. Complete hemogram, 
blood biochemistry and urinalysis proved normal. 
Sputum smear for acid fast bacilli and malignant 
cells was negative. Chest X–ray (posteroanterior 
view) showed left sided para-hilar mass with 
irregular margin. Contrast enhanced computed 
tomography (CECT) of the thorax showed a soft 
tissue mass in the left upper lobe with variegated 
appearance and irregular margin without any 
calcification, associated with left sided mediastinal 
lymphadenopathy and osteolytic erosion of left 
half of the manubrium sterni (Figure 1). 
Radioisotope bone scan using Technetium –99m 
(
99m
Tc) labeled methylene diphosphonate (MDP) 
showed sternal deposit without the involvement of 
other bones. Ultrasound of abdomen was also 
normal. Fibreoptic bronchoscopy (FOB) showed 
no endobronchial lesion and bronchoalveolar 
(BAL) lavage fluid revealed no acid fast bacillus 
or malignant cell. Fine needle aspiration cytology 
(FNAC) of left supraclavicular lymphadenopathy 
showed metastatic squamous cell carcinoma. CT-
guided FNAC of the left lung mass showed 
dispersed clusters of malignant epithelial cells 
with squamous differentiation and cytoplasmic 
keratinization in the background of inflammatory 
cells (Figure 2). CT-guided FNAC of sternal 
lesion yielded a similar cytology. Hence, final 
diagnosis was squamous cell carcinoma of left 
lung with sternum and mediastinal plus cervical 
lymph node metastases. The patient was advised 
for cytotoxic chemotherapy comprising of 
cisplatin and etoposide, but unfortunately, he 
succumbed to his illness before initiation of first 








Bone is the commonest site of metastasis from a 
primary cancer, and 80% of metastases arise from 
breast, lung, prostate, kidney, and thyroid gland 
3).  The axial skeleton is usually affected possibly 
due to the vertebral-venous plexus and the slow 
blood flow in the axial skeleton 4). Common sites 
of bony metastases are vertebrae, spine, pelvis and 
ribs 5). Isolated sternal metastasis is rare due to 
lack of vascular communication with the 
paravertebral plexus since venous drainage of the 
sternum is not through the paravertebral plexus. 
Isolated sternal metastasis by hematogenous 
spread from renal, colorectal, hematological and 
hepatic malignancy is described. (7, 9).
  
However, 
it is also rarely reported in association with lung 
cancer (7, 10).
 
Most of the sternal involvements 
are due to loco-regional extension of the adjacent 
tumour like breast cancer (11). Sternal spread may 
occur directly from the adjacent neoplasm or from 
the parasternal lymph node involvement (11). 






Fig. 2:  Photomicrograph of FNAC of left lung mass showing squamous cell carcinoma (x400, MGG stain) 
 
Bone involvement in lung cancer occurs either by 
direct extension into adjacent bones like ribs, 
sternum, thoracic vertebrae, or by hematogenous 
spread as in humerus, or lumber vertebra (12). 
Pathologically, the patients with localized rib 
involvement constitute T3 on the basis of seventh 
edition TNM staging system for lung cancer; so 
staged as stage IIB or IIIA (13). Isolated sternal 
metastasis constitutes stage IV (13). But in both 
the situations, surgery is a possible option for 
loco-regional treatment, thus sternal involvement 
either by local spread, or hematogenous 
metastases is prognostically better compared to 
distant bone metastases (2). 
Clinically, secondary sternal malignancy is 
usually asymptomatic (3). Bone pain may be 
present in 10% cases (14). The commonest sign is 
palpable mass (14), sometimes associated with 
bleeding (12).
 
Chest X-ray often reveals the 
osteolytic lesions. However, other causes of 
sternal erosion like thoracic aortic aneurysm, 
sternal surgery, infectious mediastinitis, sternal 
tuberculosis, or rheumatoid arthritis should be 
excluded. 
99m
Tc bone scan is the most cost-
effective screening test for assessment of bone 
metastasis. Isotope imaging depicts metastatic 
bone lesions as areas of increased uptake. 
However, other patterns like normal scans, 
photopenic lesions, flare phenomenon etc. are also 
possible (15). Lesions are better delineated by CT 
scan of the thorax and magnetic resonance 
imaging (MRI) of the sternum (5).
  
 CT scan is 
useful in guiding needle biopsy of the lesion. 
However, it is insensible in showing small 
intramedullary lesions. It is also unsuitable as a 
screening tool because of high radiation dose. 
MRI can detect malignant lesions before it is 
detectable with bone scans (16). MRI is helpful in 
determining the extent of local disease before 
planning surgery or radiotherapy. Metastatic 
lesions are seen as areas of hypo density on T1 
images and areas of intermediate or high signal 
intensive on T2 images. Positron emission 
tomography (PET) scan can identify bone 
metastasis at an early stage before host reaction to 
osteoblasts occurs. In a comparative study of three 
modalities, the sensitivities of PET scan, whole 
body MRI and isotope scan were 90%, 82% and 
71% respectively (17). Sternal malignancy is 
treated either with curative radiotherapy or with 
total or partial sternectomy followed by 
reconstructive surgery with myocutaneous flap 
(serratus anterior, latissimus dorsi) and prosthetic 
mesh (marlex, stainless steel mesh, teflon, nylon, 
acrylic, tantalum, polypropylene and vicryl nets, 
Gore-Tex patch) (7,18). Reconstructive surgery 
must be done with a rigid material as it prevents 
paradoxical movement of the thorax during 





respiration and provides stability of the chest wall 
and protection of intra-thoracic organ (8). Sternal 
metastasis as a part of disseminated disease should 
be treated with systemic chemotherapy (18). 
Newer or emerging moralities of treatment of 
bone metastasis include bone seeking 






rhenium, prophylactic therapy 
with bisphosphonates and denosumab, a human 
antibody targeting RANK-L (19). In our case, as 
metastases occurred in cervical and mediastinal 
lymph nodes, localized treatment of isolated 
sternal metastasis was not possible; therefore, 
systemic chemotherapy was planned. But, 
unfortunately, the patient succumbed to the 
disease before the initiation of the therapy. 
Secondary sternal tumours from lung 
primaries occur due to direct invasion or by 
hematogenous dissemination. But isolated sternal 
tumour in lung cancer is a rarity. It can be detected 
by radionuclide bone scan, and diagnosis is 
confirmed by CT-guided FNAC. Partial or 
complete resection of the sternal tumour followed 
by reconstruction with prosthetic materials 
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